FEBS Letters
Retraction Statement: miR‐188 promotes senescence of lineage‐negative bone marrow cells by targeting MAP3K3 expression
FEBS Letters, Volume 596, Issue 16, Page 2086-2086, August 2022.
FEBS Letters
The activin receptor ligand trap ActRIIB:ALK4‐Fc ameliorates cardiomyopathy induced by neuromuscular disease and diabetes
FEBS Letters, Volume 596, Issue 24, Page 3145-3158, December 2022.
FEBS Letters
Heteromerization between α1B‐adrenoceptor and chemokine (C‐C motif) receptor 2 biases α1B‐adrenoceptor signaling: Implications for vascular function
FEBS Letters, Volume 596, Issue 20, Page 2706-2716, October 2022.
FEBS Letters
Umbilical cord mesenchymal stem cell‐derived exosomes alleviate collagen‐induced arthritis by balancing the population of Th17 and regulatory T cells
FEBS Letters, Volume 596, Issue 20, Page 2668-2677, October 2022.
FEBS Letters
The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT‐20 cells in vitro
FEBS Letters, Volume 596, Issue 21, Page 2781-2794, November 2022.
FEBS Letters
Tumour suppressor p53 inhibits hepatitis C virus replication by inducing E6AP‐mediated proteasomal degradation of the viral core protein
FEBS Letters, Volume 596, Issue 19, Page 2525-2537, October 2022.
FEBS Letters
Genetic, metabolic and immunological features of cancers with NRF2 addiction
FEBS Letters, Volume 596, Issue 16, Page 1981-1993, August 2022.
FEBS Letters
Electrogenic reaction step and phospholipid translocation pathway of the mammalian P4‐ATPase ATP8A2
FEBS Letters, Volume 597, Issue 4, Page 495-503, February 2023.
FEBS Letters
Heparin promotes rapid fibrillation of the basic parathyroid hormone at physiological pH
FEBS Letters, Volume 596, Issue 22, Page 2928-2939, November 2022.